Insights On Drug Development

  1. Ask Us Anything: Cy Credille On Continuity From Discovery To Commercialization 7/24/2026

    Learn how we balance discovery and development as an asset scales, and how the One Cambrex model keeps the original process scientists attached to a molecule from first kilos through NDA.

  2. Ask Us Anything: Eric Fang On Lithiation Chemistry 7/24/2026

    Eric Fang, General Manager of Snapdragon Chemistry, on why lithiation chemistry resists batch scale-up — and how a decade spent understanding static mixing lets Snapdragon carry these reactions from milligrams to metric tons.

  3. Ask Us Anything: Eric Fang On New Challenges In Pharma Development 7/24/2026

    Eric Fang on meeting new pharmaceutical development challenges with a two-part investment — technology that answers R&D questions faster, and scientists given the support to tackle what technology can't.

  4. Ask Us Anything: Erik Feldmann On Advancing Peptide Development 7/24/2026

    Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.

  5. Ask Us Anything: Hannah McLachlan on Crystallization In Peptide Development 7/24/2026

    Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.

  6. Ask Us Anything: Michael Tracey On DoE In Process Characterization 7/24/2026

    Insights into the validation expertise behind process characterization and how deep problem-solving can turn a process into one robust enough to carry a drug to market.

  7. Keeping Future Manufacturing Options Open During Development 7/24/2026

    Early choices affect manufacturing flexibility, tech transfer, and supply chain resilience. Addressing IP and production needs early helps preserve options for commercialization.

  8. Ask Us Anything: Jillian Sheeran On Emerging Reactor Technologies 7/23/2026

    Jillian Sheeran, Associate Director of Engineering at Snapdragon Chemistry, on how automation, feedback control, and machine learning are changing reactor design — with real-time monitoring that lets a process run continuously while the data comes to you.

  9. Ask Us Anything: Mark Benger On Solid-State Strategies For Drug Development 7/23/2026

    Mark Benger, Site Director at Cambrex Edinburgh, on solid-state characterization as an insurance policy — front-loaded work that quietly determines whether a program survives the jump from kilos to tonnes.

  10. Ask Us Anything: Antje Gupta On Biocatalysts In Process Development 7/23/2026

    Antje Gupta, General Manager of Cambrex IEP in Wiesbaden, on where biocatalysis outperforms conventional chemistry — matching enzyme classes to target conversions and production volumes to find the more scalable, more economical route.